Researchers at the Australian National University can now let patients with mild cognitive impairment (MCI) know five years in advance whether they are at risk of developing Alzheimer’s disease – the most common form of dementia. “The ANU team’s research ...

Regulators in the US have approved the first new medication for Alzheimer's in nearly two decades. Aducanumab is the first medication intended to slow cognitive decline in people in the early stages of Alzheimer's. It includes antibodies designed to attach ...

Australia is witnessing a shift in public attitudes to possibly support euthanasia for people with dementia, says a leading expert on healthcare ethics. Chair in nursing at Deakin University, Professor Megan-Jane Johnstone, said alarmist and negative framing of Alzheimer’s disease ...

Figures released show spend on dementia research has increased this decade, but Alzheimer’s Australia says it’s still not enough. Darragh O Keeffe reports. The spend on research funding into Alzheimer’s and other dementias has increased tenfold since 2000, new figures ...

Research uncovers vital corner piece of the jigsaw puzzle. Australian scientists have made a significant advance in the understanding of Alzheimer's disease, a condition they describe as an accumulation of brain "rust". An imbalance in the metals needed for healthy ...